- Stoyan Karagiozov and Frank S. Abbott, “Practical Stereoselective Synthesis of (2E)- and (2Z)-4-Cycloalkyidenebut-2-enoic acids”, Synthetic Communications, 34, 871-888 (2004).
- Vincent Tong, Xiao Wei Teng, Thomas K H Chang, and Frank S Abbott, “Valproic Acid I: Time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolites in rats”, Toxicological Sciences, 86, 427-435 (2005).
- Vincent Tong, Xiao Wei Teng, Thomas K H Chang, and Frank S Abbott, “Valproic acid II: Effects on oxidative stress, mitochondrial membrane potential and cytotoxicity in glutathione-depleted rat hepatocytes”, Toxicological Sciences, 86, 436-443 (2005).
- Aspasia Michoulas, Vincent Tong, Xiao Wei Teng, Thomas Chang, Frank Abbott and Kevin Farrell, “Oxidative stress in children receiving valproic acid”, J Pediatr, 149, 692-696 (2006).
- Tony Kiang, Ping Ho, Reza Anari, Vincent Tong, Frank Abbott, and Thomas Chang, “Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype”, Toxicological Sciences, 94, 261-271 (2006).
- Chang, T. K. and Abbott, F.S. “Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity”, Drug Metab Rev 38, 627-639 (2006).
- Andrew Numa, Frank Abbott, and Thomas Chang, “Effect of Ginkgo Biloba extract on oxidative metabolism of valproic acid in hepatic microsomes from donors with the CYP2C9 *1/*1 genotype”, Can J Physiol Pharmacol 85, 848-855 (2007).
|
